• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $ONEM

    1Life Healthcare Inc.

    Subscribe to $ONEM
    $ONEM
    Medical/Nursing Services
    Health Care

    1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2020, it had approximately 549,000 members in 13 markets in the United States; and 8,000 enterprise clients. The company was incorporated in 2002 and is headquartered in San Francisco, California.

    IPO Year: 2020

    Exchange: NASDAQ

    Website: onemedical.com

    Recent Analyst Ratings for 1Life Healthcare Inc.

    DatePrice TargetRatingAnalyst
    7/12/2022$11.00 → $12.00Buy → Hold
    Deutsche Bank
    7/11/2022$11.00 → $12.00Outperform → In-line
    Evercore ISI
    7/7/2022$15.00Neutral → Buy
    BTIG Research
    5/27/2022$12.00Buy
    Stifel
    4/1/2022$15.00Outperform
    Credit Suisse
    3/30/2022Neutral
    Guggenheim
    2/25/2022$18.00 → $16.00Buy
    Deutsche Bank
    2/24/2022$24.00 → $14.00Overweight
    Morgan Stanley
    2/24/2022$37.00 → $20.00Overweight
    Piper Sandler
    2/24/2022$24.00 → $10.00Market Perform
    SVB Leerink
    See more ratings